Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiobiology with heavy charged particles: a historical review.

L D Skarsgard1

  • 1Department of Medical Biophysics, B.C. Cancer Research Centre, Vancouver, Canada.

Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)
|September 7, 2001
PubMed
Summary

Heavy charged particle radiation, including protons and heavier ions, has advanced significantly since the 1930s, offering new therapeutic possibilities. Studies show relative biological effectiveness (RBE) depends on linear energy transfer (LET) and particle type, crucial for optimizing radiation therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of correlation between G1 arrest and radiation age-response in three synchronized human tumour cell lines.

International journal of radiation biology·1999
Same author

Cell-age heterogeneity and deviations from the LQ model in the radiation survival responses of human tumour cells.

International journal of radiation biology·1999
Same author

Evidence for two forms of substructure in the cell survival curve--mechanisms and clinical consequences.

Acta oncologica (Stockholm, Sweden)·1999
Same author

Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells.

Radiation research·1997
Same author

Substructure in the cell survival response at low radiation dose: effect of different subpopulations.

International journal of radiation biology·1997
Same author

A general cavity theory.

Physics in medicine and biology·1997

Area of Science:

  • Medical Physics
  • Radiobiology
  • Particle Accelerators

Background:

  • Early radiobiological studies utilized accelerators for heavy charged particles, driven by physics and chemistry research.
  • Clinical applications of heavy charged particles (protons, helium to argon ions) began in the 1970s, with dedicated medical facilities emerging later.
  • The development of accelerators and beam systems, alongside understanding dose-response relationships, influenced the adoption of heavy ion therapy.

Observation:

  • High Linear Energy Transfer (LET) radiation, like alpha particles, demonstrated higher biological effectiveness than X-rays early on.
  • Studies in the 1960s showed Relative Biological Effectiveness (RBE) peaking at specific LET values, with Oxygen Enhancement Ratio (OER) decreasing.
  • More recent research indicates RBE depends on particle type and LET, suggesting LET alone is insufficient to define biological effects.

Related Experiment Videos

Findings:

  • RBE values for proton beams show consistency across centers, with average in vivo and in vitro values ranging from 1.11-1.18.
  • Heavy ion and pion beams exhibit increased RBE with depth, necessitating dose profile shaping to compensate for biological effectiveness changes.
  • RBE for heavier ions is also influenced by radiation dose and fractionation schedules, requiring in vivo studies for accurate measurement.

Implications:

  • Understanding RBE variations is critical for optimizing heavy charged particle therapy, particularly for heavy ions and pions.
  • Accurate mapping of RBE changes with depth and dose allows for precise physical dose shaping in treatment planning.
  • Continued research into heavy ion radiobiology, focusing on mammalian systems, is essential for advancing cancer treatment.